Combination strategies to augment oncolytic immunotherapy of cancer
发布时间:2016-11-01 来源: 阅读次数:
医学研究院2016年度学术系列讲座之十四
讲座题目：Combination strategies to augment oncolytic immunotherapy of cancer
主讲人 ：John Hiscott, Ph.D.
Director of the Pasteur Laboratory, Istituto Pasteur-Fondazione Cenci Bolognetti
讲座地点：医学部双湖大楼（8号楼）一楼会议室
讲座日期：2016-11-04
讲座时间：09：00
主讲人简介：
John Hiscott is the Director of the Pasteur Laboratory, Istituto Pasteur-Fondazione Cenci Bolognetti. The research program of Dr. Hiscott focuses on the early immune response to human pathogenic virus infection, and seeks to develop new immunotherapeutic strategies for the treatment of cancer and infectious diseases. His research has provided contributions to the understanding of the innate immune response to virus infection such as influenza, dengue, hepatitis C, and HIV. Dr. Hiscott is also involved in the development of experimental cancer therapies using oncolytic immunotherapy to specifically target and kill cancer cells. Dr. Hiscott has published more than 250 peer-reviewed research articles and invited reviews, with publications in prestigious international scientific journals, such as Science, Nature Immunology, Cell Host & Microbe, Cancer Research and Proceedings of the National Academy of Sciences USA. For his work, Dr. Hiscott has earned numerous awards and distinctions, including the Milstein Award, given by the International Society of Interferon and Cytokine Research for scientific achievement. He was the recipient of Scientist and Senior Investigator awards from the Canadian Institutes of Health Research. He also received the Distinguished Service Award from the Israel Cancer Research Fund, the Beijerinck Visiting Professorship in Virology from Leiden University Medical Center, The Netherlands and is a member of Canada’s Who’s Who. He is a member of several scientific journal editorial boards, and is Editor-in-Chief of Cytokine and Growth Factors Review, a leading immunology review journal.
Prior to joining Istituto Pasteur, Dr. Hiscott was the Director of the Viral Pathogenesis & Therapeutics program at the Vaccine & Gene Therapy Institute of Florida (2010-2015). He is currently Adjunct Professor in the Dept. of Medicine at McGill University, Montreal and previously was Professor of Medicine and Microbiology, as well as Director of the Molecular Oncology Group, Lady Davis Institute for Medical Research, McGill University. Dr. Hiscott received his doctorate degree in Medical Sciences from New York University Medical Center and completed Post-doctoral training at the Roche Institute in New Jersey and at the Institute for Molecular Biology at the University of Zurich.
欢迎各位老师同学积极参加！
